Time-related changes in full-length hepatitis C virus sequences and hepatitis activity

Virology

Volumn 263, Issue 1, 1999, Pages 244-253

  Nagayama, Kazuyoshi ^a   Kurosaki, Masayuki ^a   Enomoto, Nobuyuki ^a   Maekawa, Shin ya ^a   Miyasaka, Yuka ^a   Tazawa, Jun ichi ^b   Izumi, Namiki ^c   Marumo, Fumiaki ^a   Sato, Chifumi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^c MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS GENE; VIRUS INFECTIVITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0033543977     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9924     Document Type: Article

References (41)

1. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Ruol A. Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet. 340:1992;697-698.
2. Asahina Y., Enomoto N., Ogura Y., Kurosaki M., Sakuma I., Izumi N., Marumo F., Sato C. Sequential changes in full-length genomes of hepatitis B virus acompanying acute excerbation of chronic hepatitis B. J. Hepatol. 25:1996;787-794.
3. Behrens S. E., Tomei L. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 15:1996;12-22.
4. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
5. Cocquerel L., Meunier J. C., Pillez A., Wychowski C., Dubuisson J. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J. Virol. 72:1998;2183-2191.
6. Desmet V. J., Gerber M., Hoofnagle J. H., Manns M., Scheuer P. J. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
7. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J. Clin. Invest. 96:1995;224-230.
8. Fukuma T., Enomoto N., Marumo F., Sato C. The mutations in the interferon sensitivity determining region of hepatitis C virus and the transcriptional activity of NS5A protein. Hepatology. 28:1998;1147-1153.
9. Gale M. J., Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 230:1997;217-227.
10. Grakoui A., McCourt D. W, . Wychowski C., Feinstone S. M., Rice C. M. A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. USA. 90:1993;10583-10587.
11. Hayashi J., Kishihara Y., Yamaji K., Furusyo N., Yamamoto T., Pae Y., Etoh Y., Ikematsu H., Kashiwagi S. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology. 25:1997;697-701.
12. Kanto T., Hayashi N., Takehara T., Hagiwara H., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology. 19:1994;296-302.
13. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
14. Kato N., Lan K. H., Ono-Nita S. K., Shiratori Y., Omata M. Hepatitis C virus nonstructural region 5A is a potent transcriptional activator. J. Virol. 71:1997;8856-8859.
15. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H., Alter H. J. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology. 12:1990;671-675.
16. Koizumi K., Enomoto N., Kurosaki M., Murakami T., Izumi N., Marumo F., Sato C. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology. 22:1995;30-35.
17. Koziel M. J. The role of immune responses in the pathogenesis of hepatitis C virus infection. J. Viral Hepat. 4:1997;31-41.
18. Kurosaki M., Enomoto N., Marumo F., Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology. 18:1993;1293-1299.
19. Kurosaki M., Enomoto N., Marumo F., Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology. 205:1994;161-169.
20. Kurosaki M., Enomoto N., Marumo F., Sato C. Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis. Arch. Virol. 140:1995;1087-1094.
21. Lau J. Y., Davis G. L., Kniffen J., Qian K. P., Urdea M. S., Chan C. S., Mizokami M., Neuwald P. D., Wilber J. C. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
22. Lohmann V., Korner F., Herian U., Bartenschlager R. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71:1997;8416-8428.
23. Major M. E., Feinstone S. M. The molecular virology of hepatitis C. Hepatology. 25:1997;1527-1538.
24. Miller R. H., Purcell R. H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA. 87:1990;2057-2061.
25. Naito M., Hayashi N., Hagiwara H., Hiramatsu N., Kasahara A., Fusamoto H., Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT values. Hepatology. 19:1994;871-875.
26. Naito M., Hayashi N., Moribe T., Hagiwara H., Mita E., Kanazawa Y., Kasahara A., Fusamoto H., Kamada T. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology. 22:1995;407-412.
27. Nelson D. R., Marousis C. G., Davis G. L., Rice C. M., Wong J., Houghton M., Lau J. Y. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:1997;1473-1481.
28. Ogata N., Alter H. J., Purcell R. H. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;3392-3396.
29. Okamoto H., Kojima M., Okada S., Yoshizawa H., Iizuka H., Tanaka T., Muchmore EE., Peterson D. A., Ito Y., Mishiro S. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability. Virology. 190:1992a;894-899.
30. Okamoto H., Sugiyama Y., Okada K., Kurai K., Akahane Y., Sugai Y., Tanaka T., Sato K., Tsuda F., Miyakawa Y., Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73:1992b;673-679.
31. Prieto M., Olaso V., Verdu C., Cordoba J., Gisbert C., Rayon M., Carrasco D., Berenguer M., Higon M. D., Berenguer J. Does healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology. 22:1995;413-417.
32. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:1996;127-132.
33. Shindo M., Arai K., Sokawa Y., Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology. 22:1995;418-425.
34. Simmonds P., Alberti A., Alter H. J., Bonino F., Bradley D. W., Brechot C., Brouwer J. T., Chan S. W., Chayama K., Chen D. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 19:1994;1321-1324.
35. Smith D. B., Mellor J., Jarvis L. M., Davidson F., Kolberg J., Urdea M., Yap P. L., Simmonds P. Variation of the hepatitis C virus 5′ non-coding region: Implications for secondary structure, virus detection and typing. J. Gen. Virol. 76:1995;1749-1761.
36. Sullivan D. G., Wilson J. F., Carithers R. L. Jr., Perkins J. D., Gretch D. R. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: Correlation of genetic divirsification in the envelope region with asymptomatic or mild disease patterns. J. Virol. 72:1998;10036-10043.
37. Tanaka T., Kato N., Cho M. J., Sugiyama K., Shimotohno K. Structure of the 3′ terminus of the hepatitis of hepatitis C virus genome. J. Virol. 70:1996;3307-3312.
38. Tanji Y., Kaneko T., Satoh S., Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:1995;3980-3986.
39. Yamashita T., Kaneko S., Shirota Y., Qin W., Nomura T., Kobayashi K., Murakami S. RNA-dependant RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J. Biol. Chem. 273:1998;15479-15486.
40. Yi M., Nakamoto Y., Kaneko S., Yamashita T., Murakami S. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. Virology. 231:1997;119-129.
41. Yuki N., Hayashi N., Moribe T., Matsushita Y., Tabata T., Inoue T., Kanazawa Y., Ohkawa K., Kasahara A., Fusamoto H., Kamada T. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispesies. Hepatology. 25:1997;439-444.